Recent molecular genetic studies and methodological issues in suicide research

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 4, 2011, Pages 809-817

  Tsai, Shih Jen ^a,b   Hong, Chen Jee ^a,b   Liou, Ying Jay ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Association study; DNA microarray; Epigenetics; Genetics; Genome wide scans; Suicide behavior

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; NORTRIPTYLINE; PLACEBO;

ADRENERGIC SYSTEM; DEPRESSION; DNA MICROARRAY; DOPAMINERGIC SYSTEM; EPIGENETICS; GENE; GENE EXPRESSION PROFILING; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MARKER GENE; METHODOLOGY; MOLECULAR GENETICS; PHARMACOGENETICS; SEROTONERGIC RECEPTOR GENE; SEROTONIN TRANSPORTER GENE; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT; TRYPTOPHAN HYDROXYLASE GENE; VARIABLE NUMBER OF TANDEM REPEAT;

ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DOPAMINE; EPIGENOMICS; GENETIC ASSOCIATION STUDIES; GENOME-WIDE ASSOCIATION STUDY; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MENTAL DISORDERS; MOLECULAR BIOLOGY; PHARMACOGENETICS; RECEPTORS, SEROTONIN; RESEARCH DESIGN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SIGNAL TRANSDUCTION; SUICIDE; SUICIDE, ATTEMPTED; SYMPATHETIC NERVOUS SYSTEM; TRYPTOPHAN HYDROXYLASE;

EID: 79955986545     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.10.014     Document Type: Short Survey

References (124)

1. Anguelova M., Benkelfat C., Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior. Mol Psychiatry 2003, 8:646-653.
2. Azenha D., Alves M., Matos R., Santa J.F., Silva B., Cordeiro C., et al. Male specific association between the 5-HTR6 gene 267C/T SNP and suicide in the Portuguese population. Neurosci Lett 2009, 466:128-130.
3. Bach-Mizrachi H., Underwood M.D., Kassir S.A., Bakalian M.J., Sibille E., Tamir H., et al. Neuronal tryptophan hydroxylase mRNA expression in the human dorsal and median raphe nuclei: major depression and suicide. Neuropsychopharmacology 2006, 31:814-824.
4. Bille-Brahe U. The role of sex and age in suicidal behavior. Acta Psychiatr Scand Suppl 1993, 371:21-27.
5. Bondy B., Buettner A., Zill P. Genetics of suicide. Mol Psychiatry 2006, 11:336-351.
6. Brent D., Melhem N., Ferrell R., Emslie G., Wagner K.D., Ryan N., et al. Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study. Am J Psychiatry 2010, 167:190-197.
7. Brent D.A., Bridge J., Johnson B.A., Connolly J. Suicidal behavior runs in families. A controlled family study of adolescent suicide victims. Arch Gen Psychiatry 1996, 53:1145-1152.
8. Brent D.A., Mann J.J. Family genetic studies, suicide, and suicidal behavior. Am J Med Genet C Semin Med Genet 2005, 133C:13-24.
9. Brezo J., Klempan T., Turecki G. The genetics of suicide: a critical review of molecular studies. Psychiatr Clin North Am 2008, 31:179-203.
10. Bridge J.A., Iyengar S., Salary C.B., Barbe R.P., Birmaher B., Pincus H.A., et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. Jama 2007, 297:1683-1696.
11. Campos S.B., Miranda D.M., Souza B.R., Pereira P.A., Neves F.S., Bicalho M.A., et al. Association of polymorphisms of the tryptophan hydroxylase 2 gene with risk for bipolar disorder or suicidal behavior. J Psychiatr Res 2010, 44:271-274.
12. Cicchetti D., Rogosch F.A., Sturge-Apple M., Toth S.L. Interaction of child maltreatment and 5-HTT polymorphisms: suicidal ideation among children from low-SES backgrounds. J Pediatr Psychol 2010, 35:536-546.
13. Collier D.A., Stober G., Li T., Heils A., Catalano M., Di Bella D., et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry 1996, 1:453-460.
14. Courtet P., Jollant F., Buresi C., Castelnau D., Mouthon D., Malafosse A. The monoamine oxidase A gene may influence the means used in suicide attempts. Psychiatr Genet 2005, 15:189-193.
15. Coventry W.L., James M.R., Eaves L.J., Gordon S.D., Gillespie N.A., Ryan L., et al. Do 5HTTLPR and stress interact in risk for depression and suicidality? Item response analyses of a large sample. Am J Med Genet B Neuropsychiatr Genet 2010, 153B:757-765.
16. Cui H., Nishiguchi N., Ivleva E., Yanagi M., Fukutake M., Nushida H., et al. Association of RGS2 gene polymorphisms with suicide and increased RGS2 immunoreactivity in the postmortem brain of suicide victims. Neuropsychopharmacology 2008, 33:1537-1544.
17. Cui H., Supriyanto I., Asano M., Ueno Y., Nagasaki Y., Nishiguchi N., et al. A common polymorphism in the 3'-UTR of the NOS1 gene was associated with completed suicides in Japanese male population. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:992-996.
18. De Luca V., Likhodi O., Van Tol H.H., Kennedy J.L., Wong A.H. Gene expression of tryptophan hydroxylase 2 in post-mortem brain of suicide subjects. Int J Neuropsychopharmacol 2006, 9:21-25.
19. De Luca V., Mueller D.J., Tharmalingam S., King N., Kennedy J.L. Analysis of the novel TPH2 gene in bipolar disorder and suicidality. Mol Psychiatry 2004, 9:896-897.
20. De Luca V., Tharmalingam S., Kennedy J.L. Association study between the corticotropin-releasing hormone receptor 2 gene and suicidality in bipolar disorder. Eur Psychiatry 2007, 22:282-287.
21. De Luca V., Tharmalingam S., Müller D.J., Wong G., de Bartolomeis A., Kennedy J.L. Gene-gene interaction between MAOA and COMT in suicidal behavior: analysis in schizophrenia. Brain Res 2006, 1097:26-30.
22. De Luca V., Tharmalingam S., Sicard T., Kennedy J.L. Gene-gene interaction between MAOA and COMT in suicidal behavior. Neurosci Lett 2005, 383:151-154.
23. De Luca V., Tharmaligam S., Strauss J., Kennedy J.L. 5-HT2C receptor and MAO-A interaction analysis: no association with suicidal behaviour in bipolar patients. Eur Arch Psychiatry Clin Neurosci 2008, 258:428-433.
24. De Luca V., Tharmalingam S., Zai C., Potapova N., Strauss J., Vincent J., et al. Association of HPA axis genes with suicidal behaviour in schizophrenia. J Psychopharmacol 2010, 24:677-682.
25. De Luca V., Voineskos D., Wong G.W., Shinkai T., Rothe C., Strauss J., et al. Promoter polymorphism of second tryptophan hydroxylase isoform (TPH2) in schizophrenia and suicidality. Psychiatry Res 2005, 134:195-198.
26. De Paermentier F., Mauger J.M., Lowther S., Crompton M.R., Katona C.L., Horton R.W. Brain alpha-adrenoceptors in depressed suicides. Brain Res 1997, 757:60-68.
27. Du L., Faludi G., Palkovits M., Bakish D., Hrdina P.D. Serotonergic genes and suicidality. Crisis 2001, 22:54-60.
28. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006, 59:1116-1127.
29. Dwivedi Y. Brain-derived neurotrophic factor and suicide pathogenesis. Ann Med 2010, 42:87-96.
30. Dwivedi Y., Rizavi H.S., Conley R.R., Roberts R.C., Tamminga C.A., Pandey G.N. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003, 60:804-815.
31. Ernst C., Deleva V., Deng X., Sequeira A., Pomarenski A., Klempan T., et al. Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers. Arch Gen Psychiatry 2009, 66:22-32.
32. Fiori L.M., Turecki G. Genetic and epigenetic influences on expression of spermine synthase and spermine oxidase in suicide completers. Int J Neuropsychopharmacol 2010, 13:725-736.
33. Fudalej S., Fudalej M., Kostrzewa G., Kuźniar P., Franaszczyk M., Wojnar M., et al. Angiotensin-converting enzyme polymorphism and completed suicide: an association in Caucasians and evidence for a link with a method of self-injury. Neuropsychobiology 2009, 59:151-158.
34. Fukutake M., Hishimoto A., Nishiguchi N., Nushida H., Ueno Y., Shirakawa O., et al. Association of alpha2A-adrenergic receptor gene polymorphism with susceptibility to suicide in Japanese females. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1428-1433.
35. Gibb B.E., McGeary J.E., Beevers C.G., Miller I.W. Serotonin transporter (5-HTTLPR) genotype, childhood abuse, and suicide attempts in adult psychiatric inpatients. Suicide Life Threat Behav 2006, 36:687-693.
36. Guipponi M., Deutsch S., Kohler K., Perroud N., Le Gal F., Vessaz M., et al. Genetic and epigenetic analysis of SSAT gene dysregulation in suicidal behavior. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:799-807.
37. Hammad T.A., Laughren T., Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006, 63:332-339.
38. Hawton K., van Heeringen K. Suicide. Lancet 2009, 373:1372-1381.
39. Henriksson M.M., Aro H.M., Marttunen M.J., Heikkinen M.E., Isometsä E.T., Kuoppasalmi K.I., et al. Mental disorders and comorbidity in suicide. Am J Psychiatry 1993, 150:935-940.
40. Hishimoto A., Shirakawa O., Nishiguchi N., Hashimoto T., Yanagi M., Nushida H., et al. Association between a functional polymorphism in the renin-angiotensin system and completed suicide. J Neural Transm 2006, 113:1915-1920.
41. Hong C.J., Huo S.J., Yen F.C., Tung C.L., Pan G.M., Tsai S.J. Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 2003, 48:186-189.
42. Hong C.J., Wang Y.C., Tsai S.J. Association study of angiotensin I-converting enzyme polymorphism and symptomatology and antidepressant response in major depressive disorders. J Neural Transm 2002, 109:1209-1214.
43. Hu X.Z., Lipsky R.H., Zhu G., Akhtar L.A., Taubman J., Greenberg B.D., et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 2006, 78:815-826.
44. Huang T.L., Lee C.T. Associations between brain-derived neurotrophic factor G196A gene polymorphism and clinical phenotypes in schizophrenia patients. Chang Gung Med J 2007, 30:408-413.
45. Huang Y.Y., Battistuzzi C., Oquendo M.A., Harkavy-Friedman J., Greenhill L., Zalsman G., et al. Human 5-HT1A receptor C(-1019)G polymorphism and psychopathology. Int J Neuropsychopharmacol 2004, 7:441-451.
46. Hwang J.P., Tsai S.J., Hong C.J., Yang C.H., Lirng J.F., Yang Y.M. The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol Aging 2006, 27:1834-1837.
47. Hwang J.P., Yang C.H., Hong C.J., Lirng J.F., Yang Y.M., Tsai S.J. Association of APOE genetic polymorphism with cognitive function and suicide history in geriatric depression. Dement Geriatr Cogn Disord 2006, 22:334-338.
48. Iga J., Ueno S., Yamauchi K., Numata S., Tayoshi-Shibuya S., Kinouchi S., et al. The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients. Am J Med Genet B Neuropsychiatr Genet 2007, 144B:1003-1006.
49. Johann M., Putzhammer A., Eichhammer P., Wodarz N. Association of the -141C Del variant of the dopamine D2 receptor (DRD2) with positive family history and suicidality in German alcoholics. Am J Med Genet B Neuropsychiatr Genet 2005, 132B:46-49.
50. Karege F., Vaudan G., Schwald M., Perroud N., La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res 2005, 136:29-37.
51. Ke L., Qi Z.Y., Ping Y., Ren C.Y. Effect of SNP at position 40237 in exon 7 of the TPH2 gene on susceptibility to suicide. Brain Res 2006, 1122:24-26.
52. Keller S., Sarchiapone M., Zarrilli F., Videtic A., Ferraro A., Carli V., et al. Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch Gen Psychiatry 2010, 67:258-267.
53. Kia-Keating B.M., Glatt S.J., Tsuang M.T. Meta-analyses suggest association between COMT, but not HTR1B, alleles, and suicidal behavior. Am J Med Genet B Neuropsychiatr Genet 2007, 144B:1048-1053.
54. Kim B., Kim C.Y., Hong J.P., Kim S.Y., Lee C., Joo Y.H. Brain-derived neurotrophic factor Val/Met polymorphism and bipolar disorder. Association of the Met allele with suicidal behavior of bipolar patients. Neuropsychobiology 2008, 58:97-103.
55. Kim Y.K., Lee H.P., Won S.D., Park E.Y., Lee H.Y., Lee B.H., et al. Low plasma BDNF is associated with suicidal behavior in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:78-85.
56. Kohli M.A., Salyakina D., Pfennig A., Lucae S., Horstmann S., Menke A., et al. Association of genetic variants in the neurotrophic receptor-encoding gene NTRK2 and a lifetime history of suicide attempts in depressed patients. Arch Gen Psychiatry 2010, 67:348-359.
57. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996, 6:243-250.
58. Laje G., Allen A.S., Akula N., Manji H., John Rush A., McMahon F.J. Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients. Pharmacogenet Genomics 2009, 19:666-674.
59. Laje G., Paddock S., Manji H., Rush A.J., Wilson A.F., Charney D., et al. Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. Am J Psychiatry 2007, 164:1530-1538.
60. Lemonde S., Turecki G., Bakish D., Du L., Hrdina P.D., Bown C.D., et al. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 2003, 23:8788-8799.
61. Levi F., La Vecchia C., Lucchini F., Negri E., Saxena S., Maulik P.K., et al. Trends in mortality from suicide, 1965-99. Acta Psychiatr Scand 2003, 108:341-349.
62. Levinson D.F. Genetics and suicidal ideation during antidepressant treatment. Am J Psychiatry 2008, 165:395.
63. Li D., Duan Y., He L. Association study of serotonin 2A receptor (5-HT2A) gene with schizophrenia and suicidal behavior using systematic meta-analysis. Biochem Biophys Res Commun 2006, 340:1006-1015.
64. Li D., He L. Further clarification of the contribution of the tryptophan hydroxylase (TPH) gene to suicidal behavior using systematic allelic and genotypic meta-analyses. Hum Genet 2006, 119:233-240.
65. Li D., He L. Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behavior. Mol Psychiatry 2007, 12:47-54.
66. Lin P.Y., Tsai G. Association between serotonin transporter gene promoter polymorphism and suicide: results of a meta-analysis. Biol Psychiatry 2004, 55:1023-1030.
67. Lopez de Lara C., Brezo J., Rouleau G., Lesage A., Dumont M., Alda M. Effect of tryptophan hydroxylase-2 gene variants on suicide risk in major depression. Biol Psychiatry 2007, 62:72-80.
68. Lopez V.A., Detera-Wadleigh S., National Institute of Mental Health Genetics Initiative Bipolar Disorder Consortium, Kassem L., McMahon F.J. Nested association between genetic variation in tryptophan hydroxylase II, bipolar affective disorder, and suicide attempts. Biol Psychiatry 2007, 61:181-186.
69. Lou X.Y., Chen G.B., Yan L., Ma J.Z., Zhu J., Elston R.C., et al. A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet 2007, 80:1125-1137.
70. Magno L.A., Miranda D.M., Neves F.S., Pimenta G.J., Mello M.P., De Marco L.A., et al. Association between AKT1 but not AKTIP genetic variants and increased risk for suicidal behavior in bipolar patients. Genes Brain Behav 2010, 9:411-418.
71. Maisonpierre P.C., Belluscio L., Friedman B., Alderson R.F., Wiegand S.J., Furth M.E., et al. NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression. Neuron 1990, 5:501-509.
72. Mann J.J., Arango V.A., Avenevoli S., Brent D.A., Champagne F.A., Clayton P., et al. Candidate endophenotypes for genetic studies of suicidal behavior. Biol Psychiatry 2009, 65:556-563.
73. Mann J.J., Currier D., Murphy L., Huang Y.Y., Galfalvy H., Brent D., et al. No association between a TPH2 promoter polymorphism and mood disorders or monoamine turnover. J Affect Disord 2008, 106:117-121.
74. McGowan P.O., Sasaki A., D'Alessio A.C., Dymov S., Labonté B., Szyf M., et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009, 12:342-348.
75. McGowan P.O., Sasaki A., Huang T.C., Unterberger A., Suderman M., Ernst C., et al. Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain. PLoS ONE 2008, 3:e2085.
76. McGregor S., Strauss J., Bulgin N., De Luca V., George C.J., Kovacs M., et al. p75(NTR) gene and suicide attempts in young adults with a history of childhood-onset mood disorder. Am J Med Genet B Neuropsychiatr Genet 2007, 144B:696-700.
77. Mouri K., Hishimoto A., Fukutake M., Shiroiwa K., Asano M., Nagasaki Y., et al. TPH2 is not a susceptibility gene for suicide in Japanese population. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:1546-1550.
78. Munafò M.R., Durrant C., Lewis G., Flint J. Gene X environment interactions at the serotonin transporter locus. Biol Psychiatry 2009, 65:211-219.
79. Must A., Tasa G., Lang A., Vasar E., Kõks S., Maron E., et al. Variation in tryptophan hydroxylase-2 gene is not associated to male completed suicide in Estonian population. Neurosci Lett 2009, 453:112-114.
80. New A.S., Gelernter J., Goodman M., Mitropoulou V., Koenigsberg H., Silverman J., et al. Suicide, impulsive aggression, and HTR1B genotype. Biol Psychiatry 2001, 50:62-65.
81. Nishiguchi N., Shirakawa O., Ono H., Nishimura A., Nushida H., Ueno Y., et al. Lack of an association between 5-HT1A receptor gene structural polymorphisms and suicide victims. Am J Med Genet 2002, 114:423-425.
82. Ono H., Shirakawa O., Nishiguchi N., Nishimura A., Nushida H., Ueno Y., et al. No evidence of an association between a functional monoamine oxidase a gene polymorphism and completed suicides. Am J Med Genet 2002, 114:340-342.
83. Oswald L.M., Wong D.F., Zhou Y., Kumar A., Brasic J., Alexander M., et al. Impulsivity and chronic stress are associated with amphetamine-induced striatal dopamine release. Neuroimage 2007, 36:153-166.
84. Pandey G.N., Ren X., Rizavi H.S., Conley R.R., Roberts R.C., Dwivedi Y. Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims. Int J Neuropsychopharmacol 2008, 11:1047-1061.
85. Perlis R.H., Purcell S., Fava M., Fagerness J., Rush A.J., Trivedi M.H., et al. Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. Arch Gen Psychiatry 2007, 64:689-697.
86. Perroud N., Aitchison K.J., Uher R., Smith R., Huezo-Diaz P., Marusic A., et al. Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project. Neuropsychopharmacology 2009, 34:2517-2528.
87. Perroud N., Courtet P., Vincze I., Jaussent I., Jollant F., Bellivier F., et al. Interaction between BDNF Val66Met and childhood trauma on adult's violent suicide attempt. Genes Brain Behav 2008, 7:314-322.
88. Perroud N., Neidhart E., Petit B., Vessaz M., Laforge T., Relecom C., et al. Simultaneous analysis of serotonin transporter, tryptophan hydroxylase 1 and 2 gene expression in the ventral prefrontal cortex of suicide victims. Am J Med Genet B Neuropsychiatr Genet 2010, 153B:909-918.
89. Pezet S., Malcangio M. Brain-derived neurotrophic factor as a drug target for CNS disorders. Expert Opin Ther Targets 2004, 8:391-399.
90. Pompili M., Serafini G., Innamorati M., Möller-Leimkühler A.M., Giupponi G., Girardi P., et al. The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention. Eur Arch Psychiatry Clin Neurosci 2010, 260(8):583-600.
91. Poulter M.O., Du L., Weaver I.C., Palkovits M., Faludi G., Merali Z., et al. GABAA receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes. Biol Psychiatry 2008, 64:645-652.
92. Roy A., Gorodetsky E., Yuan Q., Goldman D., Enoch M.A. Interaction of FKBP5, a stress-related gene, with childhood trauma increases the risk for attempting suicide. Neuropsychopharmacology 2010, 35:1674-1683.
93. Roy A., Hu X.Z., Janal M.N., Goldman D. Interaction between childhood trauma and serotonin transporter gene variation in suicide. Neuropsychopharmacology 2007, 32:2046-2052.
94. Roy A., Sarchiopone M., Carli V. Gene-environment interaction and suicidal behavior. J Psychiatr Pract 2009, 15:282-288.
95. Ryding E., Lindström M., Träskman-Bendz L. The role of dopamine and serotonin in suicidal behaviour and aggression. Prog Brain Res 2008, 172:307-315.
96. Sarchiapone M., Carli V., Roy A., Iacoviello L., Cuomo C., Latella M.C., et al. Association of polymorphism (Val66Met) of brain-derived neurotrophic factor with suicide attempts in depressed patients. Neuropsychobiology 2008, 57:139-145.
97. Sawiniec J., Borkowski K., Ginalska G., Lewandowska-Stanek H. Association between 5-hydroxytryptamine 1A receptor gene polymorphism and suicidal behavior. Przegl Lek 2007, 64:208-211.
98. Schenkel L.C., Segal J., Becker J.A., Manfro G.G., Bianchin M.M., Leistner-Segal S. The BDNF Val66Met polymorphism is an independent risk factor for high lethality in suicide attempts of depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:940-944.
99. Segal J., Schenkel L.C., Oliveira M.H., Salum G.A., Bau C.H., Manfro G.G., et al. Novel allelic variants in the human serotonin transporter gene linked polymorphism (5-HTTLPR) among depressed patients with suicide attempt. Neurosci Lett 2009, 451:79-82.
100. Sequeira A., Gwadry F.G., Ffrench-Mullen J.M., Canetti L., Gingras Y., Casero R.A., et al. Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psychiatry 2006, 63:35-48.
101. Sequeira A., Mamdani F., Lalovic A., Anguelova M., Lesage A., Seguin M., et al. Alpha 2A adrenergic receptor gene and suicide. Psychiatry Res 2004, 125:87-93.
102. Shindo S., Yoshioka N. Polymorphisms of the cholecystokinin gene promoter region in suicide victims in Japan. Forensic Sci Int 2005, 150:85-90.
103. Sparks D.L., Hunsaker J.C., Amouyel P., Malafosse A., Bellivier F., Leboyer M., et al. Angiotensin I-converting enzyme I/D polymorphism and suicidal behaviors. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:290-294.
104. Stone M., Laughren T., Jones M.L., Levenson M., Holland P.C., Hughes A., et al. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. Bmj 2009, 339:b2880.
105. Suda A., Kawanishi C., Kishida I., Sato R., Yamada T., Nakagawa M., et al. Dopamine D2 receptor gene polymorphisms are associated with suicide attempt in the Japanese population. Neuropsychobiology 2009, 59:130-134.
106. Tsai S.J. Possible involvement of the BDNF-dependent pathway in treatment-emergent suicidality or decreased response to antidepressants. Med Hypotheses 2005, 65:942-946.
107. Tsankova N., Renthal W., Kumar A., Nestler E.J. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 2007, 8:355-367.
108. Turecki G. Suicidal behavior: is there a genetic predisposition?. Bipolar Disord 2001, 3:335-349.
109. Videtic A., Peternelj T.T., Zupanc T., Balazic J., Komel R. Promoter and functional polymorphisms of HTR2C and suicide victims. Genes Brain Behav 2009, 8:541-545.
110. Videtic A., Zupanc T., Pregelj P., Balazic J., Tomori M., Komel R. Suicide, stress and serotonin receptor 1A promoter polymorphism -1019C>G in Slovenian suicide victims. Eur Arch Psychiatry Clin Neurosci 2009, 259:234-238.
111. Vincze I., Perroud N., Buresi C., Baud P., Bellivier F., Etain B., et al. Association between brain-derived neurotrophic factor gene and a severe form of bipolar disorder, but no interaction with the serotonin transporter gene. Bipolar Disord 2008, 10:580-587.
112. Voracek M., Loibl L.M. Genetics of suicide: a systematic review of twin studies. Wien Klin Wochenschr 2007, 119:463-475.
113. Walther D.J., Bader M. A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 2003, 66:1673-1680.
114. Walther D.J., Peter J.U., Bashammakh S., Hörtnagl H., Voits M., Fink H., et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 2003, 299:76.
115. Wang S., Zhang K., Xu Y., Sun N., Shen Y., Xu Q. An association study of the serotonin transporter and receptor genes with the suicidal ideation of major depression in a Chinese Han population. Psychiatry Res 2009, 170:204-207.
116. Wasserman D., Sokolowski M., Rozanov V., Wasserman J. The CRHR1 gene: a marker for suicidality in depressed males exposed to low stress. Genes Brain Behav 2008, 7:14-19.
117. Willour V.L., Chen H., Toolan J., Belmonte P., Cutler D.J., Goes F.S., et al. Family-based association of FKBP5 in bipolar disorder. Mol Psychiatry 2009, 14:261-268.
118. Yanagi M., Shirakawa O., Kitamura N., Okamura K., Sakurai K., Nishiguchi N., et al. Association of 14-3-3 epsilon gene haplotype with completed suicide in Japanese. J Hum Genet 2005, 50:210-216.
119. Yoon H.K., Kim Y.K. TPH2 -703G/T SNP may have important effect on susceptibility to suicidal behavior in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:403-409.
120. Zarrilli F., Angiolillo A., Castaldo G., Chiariotti L., Keller S., Sacchetti S., et al. Brain derived neurotrophic factor (BDNF) genetic polymorphism (Val66Met) in suicide: a study of 512 cases. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:599-600.
121. Zhou Z., Roy A., Lipsky R., Kuchipudi K., Zhu G., Taubman J., et al. Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations. Arch Gen Psychiatry 2005, 62:1109-1118.
122. Zill P., Büttner A., Eisenmenger W., Möller H.J., Bondy B., Ackenheil M. Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims. Biol Psychiatry 2004, 56:581-586.
123. Zill P., Büttner A., Eisenmenger W., Müller J., Möller H.J., Bondy B. Predominant expression of tryptophan hydroxylase 1 mRNA in the pituitary: a postmortem study in human brain. Neuroscience 2009, 159:1274-1282.
124. Zill P., Preuss U.W., Koller G., Bondy B., Soyka M. SNP- and haplotype analysis of the tryptophan hydroxylase 2 gene in alcohol-dependent patients and alcohol-related suicide. Neuropsychopharmacology 2007, 32:1687-1694.